Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
News & Press: Breaking News

FDA Today Announces Pharmacy Compounding Advisory Committee Members

Tuesday, December 16, 2014   (0 Comments)
Share |

The U.S. Food and Drug Administration (FDA) today announced the membership of the Pharmacy Compounding Advisory Committee. The committee is comprised of 14 members  - 12 voting and two non-voting - who will provide advice on scientific, technical and medical issues concerning drug compounding under sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act.


Please click here for FDA's announcement.


IACP's Executive Vice President/CEO David G. Miller, RPh, comments, "We are glad to see that the FDA has put the Pharmacy Compounding Advisory Committee in place and we hope that this process will result in an implementation of DQSA that is more consistent with the intent of the law.


While we are pleased that the advisory committee finally has been announced and that the members are well-qualified scientifically, IACP has serious concerns about the lack of representation on the panel of actual practicing compounding pharmacists. IACP submitted 24 nominees, many with extensive real-life compounding practice experience, to the FDA and only one was selected."

Association Management Software Powered by®  ::  Legal